Growth in patients with mucopolysaccharidosis type III (Sanfilippo disease)

Journal of Inherited Metabolic Disease

Volumn 37, Issue 3, 2014, Pages 447-454

  De Ruijter, J ^a   Broere, L ^a   Mulder, M F ^b   Van Der Ploeg, A T ^c   Rubio Gozalbo, M E ^d   Wortmann, S B ^e   Visser, G ^f   Wijburg, F A ^a,g  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c ERASMUS MEDICAL CENTER   (Netherlands)

^d MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^e RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^f UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^g ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BIRTH WEIGHT; BODY HEIGHT; BODY MASS; BODY WEIGHT; CHILD; DISEASE SEVERITY; FEMALE; GENOTYPE; GESTATIONAL AGE; GROUPS BY AGE; GROWTH CURVE; HEAD CIRCUMFERENCE; HUMAN; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; SANFILIPPO SYNDROME; SCHOOL CHILD; STUNTING; YOUNG ADULT; PATHOPHYSIOLOGY;

ADOLESCENT; ADULT; BIRTH WEIGHT; BODY HEIGHT; BODY MASS INDEX; BODY WEIGHT; CHILD; FEMALE; HUMANS; MALE; MUCOPOLYSACCHARIDOSIS III;

EID: 84904183621     PISSN: 01418955     EISSN: 15732665     Source Type: Journal    
DOI: 10.1007/s10545-013-9658-3     Document Type: Article

References (51)

1. Aldenhoven M, Sakkers RJ, Boelens J, de Koning TJ, Wulffraat NM (2009) Musculoskeletal manifestations of lysosomal storage disorders. Ann Rheum Dis 68:1659-1665
2. Beesley CE, Jackson M, Young EP, Vellodi A, Winchester BG (2005) Molecular defects in Sanf i l ippo syndrome type B (mucopolysaccharidosis IIIB). J Inherit Metab Dis 28:759-767 (Pubitemid 41349263)
3. Bunge S, Ince H, Steglich C et al (1997) Identification of 16 sulfamidase gene mutations including the common R74C in patients with mucopolysaccharidosis type IIIA (Sanfilippo A). Hum Mutat 10:479-485 (Pubitemid 27523061)
4. Cianfarani S, Holly JM (1989) Somatomedin-binding proteins: what role do they play in the growth process? Eur J Pediatr 149:76-79 (Pubitemid 20000985)
5. Clarke LA (2011) Pathogenesis of skeletal and connective tissue involvement in the mucopolysaccharidoses: Glycosaminoglycan storage ismerely the instigator. Rheumatology (Oxford) 50(5):v13-v18
6. Cleary MA, Wraith JE (1993) Management of mucopolysaccharidosis type III. Arch Dis Child 69:403-406 (Pubitemid 23291335)
7. Cole TJ, Green PJ (1992) Smoothing reference centile curves: The LMS method and penalized likelihood. Stat Med 11:1305-1319
8. de Jonge GA (1986) Primaire en secundaire preventie van congenitale heupluxatie. Ned Tijdschr Geneeskd 17:12-13
9. deWijn J, de Haas J (1960) Growth diagrams for ages 1-25 years in The Netherlands. [Leiden: Wolters-noordhoff] 1-29.
10. de Ruijter J, Maas M, Janssen A, Wijburg FA (2013) High prevalence of femoral head necrosis inMucopolysaccharidosis type III (Sanfilippo disease): A national, observational, cross-sectional study. Mol Genet Metab 109:49-53
11. Di Natale P, Balzano N, Esposito S, Villani GR (1998) Identification of molecular defects in Italian Sanfilippo A patients including 13 novel mutations. Hum Mutat 11:313-320 (Pubitemid 28177873)
12. Fredriks AM, van Buuren S, Burgmeijer RJ (2000) Continuing positive secular growth change in The Netherlands 1955-1997. Pediatr Res 47:316-323 (Pubitemid 30127036)
13. Gesslbauer B, Rek A, Falsone F, Rajkovic E, Kungl AJ (2007) Proteoglycanomics: tools to unravel the biological function of glycosaminoglycans. Proteomics 7:2870-2880 (Pubitemid 47359927)
14. Giugliani R (2012) Mucopolysacccharidoses: From understanding to treatment, a century of discoveries. Genet Mol Biol 35:924-931
15. Jones SA, Parini R, Harmatz P, Giugliani R, Fang J, Mendelsohn NJ (2013) The effect of idursulfase on growth in patients with Hunter syndrome: data from the Hunter Outcome Survey (HOS). Mol Genet Metab 109:41-48
16. Kalkan US, Ozbaran B, Demiral N, Yuncu Z, Erermis S, CokerM(2010) Clinical overview of children with mucopolysaccharidosis type III A and effect of Risperidone treatment on children and their mothers psychological status. Brain Dev 32:156-161
17. Kloosterman GJ (1969) Intrauterine growth and intrauterine growth curves. Ned Tijdschr Verloskd Gynaecol 69:349-365
18. Maiano C (2011) Prevalence and risk factors of overweight and obesity among children and adolescents with intellectual disabilities. Obes Rev 12:189-197
19. Montano AM, Tomatsu S, Brusius A, Smith M, Orii T (2008) Growth charts for patients affected with Morquio A disease. Am J Med Genet A 146A:1286-1295 (Pubitemid 351631325)
20. Morishita K, Petty RE (2011) Musculoskeletal manifestations of mucopolysaccharidoses. Rheumatology (Oxford) 50(5):v19-v25
21. Muschol N, Pohl S, Meyer A, Gal A, Ullrich K, Braulke T (2011) Residual activity and proteasomal degradation of p.Ser298Pro sulfamidase identified in patients with a mild clinical phenotype of Sanfilippo A syndrome. Am J Med Genet A 155A:1634-1639
22. Muschol N, Storch S, Ballhausen D et al (2004) Transport, enzymatic activity, and stability of mutant sulfamidase (SGSH) identified in patients with mucopolysaccharidosis type III A. Hum Mutat 23:559-566 (Pubitemid 38720607)
23. Niklasson A, Albertsson-Wikland K (2008) Continuous growth reference from 24th week of gestation to 24months by gender. BMC Pediatr 8:8
24. Polgreen LE, Miller BS (2010) Growth patterns and the use of growth hormone in the mucopolysaccharidoses. J Pediatr Rehabil Med 3:25-38
25. Polgreen LE, Tolar J, PlogMet al (2008) Growth and endocrine function in patients with Hurler syndrome after hematopoietic stem cell transplantation. Bone Marrow Transplant 41:1005-1011 (Pubitemid 352034175)
26. Poorthuis BJ, Wevers RA, Kleijer WJ et al (1999) The frequency of lysosomal storage diseases in The Netherlands. Hum Genet 105:151-156 (Pubitemid 29396979)
27. RoedeMJ (1990) The secular trend in The Netherlands. The third nationwide growth study. Arztl Jugendkd 81:330-336
28. Rozdzynska A, Tylki-Szymanska A, Jurecka A, Cieslik J (2011) Growth pattern and growth prediction of body height in children with mucopolysaccharidosis type II. Acta Paediatr 100:456-460
29. Ruijter GJ, ValstarMJ, van de Kamp JM et al (2008) Clinical and genetic spectrum of Sanfilippo type C (MPS IIIC) disease in The Netherlands. Mol Genet Metab 93:104-111
30. Sasisekharan R, Raman R, Prabhakar V (2006) Glycomics approach to structure-function relationships of glycosaminoglycans. Annu Rev Biomed Eng 8:181-231 (Pubitemid 44314816)
31. Schonbeck Y, Talma H, van Dommelen P et al (2011) Increase in prevalence of overweight in Dutch children and adolescents: a comparison of nationwide growth studies in 1980, 1997 and 2009. PLoS One 6:e27608
32. Schonbeck Y, Talma H, van Dommelen P (2012) The world's tallest nation has stopped growing taller: the height of Dutch children 1955-2009. Pediatr Res 73:371-377
33. Simonaro CM, D'Angelo M, He X et al (2008) Mechanism of glycosaminoglycan-mediated bone and joint disease: Implications for the mucopolysaccharidoses and other connective tissue diseases. Am J Pathol 172:112-122
34. Swiedler SJ, Beck M, Bajbouj M et al (2005) Threshold effect of urinary glycosaminoglycans and the walk test as indicators of disease progression in a survey of subjects with Mucopolysaccharidosis VI (Maroteaux-Lamy syndrome). Am J Med Genet A 134A:144-150 (Pubitemid 40446209)
35. Tessitore A, Villani GR, Di DC, Filocamo M, Gatti R, Di Natale P (2000) Molecular defects in the alpha-N-acetylglucosaminidase gene in Italian Sanfilippo type B patients. Hum Genet 107:568-576 (Pubitemid 32010958)
36. Tylki-Szymanska A, Rozdzynska A, Jurecka A, Marucha J, Czartoryska B (2010) Anthropometric data of 14 patients with mucopolysaccharidosis I: Retrospective analysis and efficacy of recombinant human alpha-L-iduronidase (laronidase). Mol Genet Metab 99:10-17
37. Valstar MJ, Bruggenwirth HT, Olmer R et al (2010a) Mucopolysaccharidosis type IIIB may predominantly present with an attenuated clinical phenotype. J Inherit Metab Dis 33:759-767
38. Valstar MJ, Neijs S, Bruggenwirth HT et al (2010b) Mucopolysaccharidosis type IIIA: Clinical spectrum and genotype-phenotype correlations. Ann Neurol 68:876-887
39. Valstar MJ, Ruijter GJ, van Diggelen OP, Poorthuis BJ, Wijburg FA (2008) Sanfilippo syndrome: A mini-review. J Inherit Metab Dis 31:240-252
40. van de Kamp JJ, Niermeijer MF, von Figura K, Giesberts MA (1981) Genetic heterogeneity and clinical variability in the Sanfilippo syndrome (types A, B, and C). Clin Genet 20:152-160 (Pubitemid 11027917)
41. vanWieringen J, Wafelbakker F, Verbrugge H, de Haas J (1971) Growth diagrams 1965 Netherlands. Wolters-Noordhoff, Leiden, pp 1-69
42. VerhoevenWM, Csepan R, Marcelis CL, Lefeber DJ, Egger JI, Tuinier S (2010) Sanfilippo B in an elderly female psychiatric patient: a rare but relevant diagnosis in presenile dementia. Acta Psychiatr Scand 122:162-165
43. Weber B, Guo XH, Kleijer WJ, van de Kamp JJ, Poorthuis BJ, Hopwood JJ (1999) Sanfilippo type B syndrome (mucopolysaccharidosis III B): allelic heterogeneity corresponds to thewide spectrumof clinical phenotypes. Eur J Hum Genet 7:34-44 (Pubitemid 29179030)
44. Weber B, Guo XH, Wraith JE et al (1997) Novel mutations in Sanfilippo A syndrome: Implications for enzyme function. Hum Mol Genet 6:1573-1579 (Pubitemid 27397036)
45. White KK (2011) Orthopaedic aspects of mucopolysaccharidoses. Rheumatology 50(5):v26-v33
46. Woods CG (2004) Humanmicrocephaly. Curr Opin Neurobiol 14:112-117
47. Wraith JE, Beck M, Giugliani R, Clarke J, Martin R, Muenzer J (2008) Initial report from the hunter outcome survey. Genet Med 10:508-516
48. Yogalingam G, Hopwood JJ (2001) Molecular genetics of mucopolysaccharidosis type IIIA and IIIB: Diagnostic, clinical, and biological implications. Hum Mutat 18:264-281 (Pubitemid 32916858)
49. Young ID, Harper PS (1983) The natural history of the severe form of Hunter 's syndrome: A study based on 52 cases. Dev Med Child Neurol 25:481-489 (Pubitemid 13030892)
50. Zhao HG, Aronovich EL, Whitley CB (1998) Genotype-phenotype correspondence in Sanfilippo syndrome type B. Am J Hum Genet 62:53-63 (Pubitemid 28093834)
51. Zhao HG, Li HH, Bach G, Schmidtchen A, Neufeld EF (1996) The molecular basis of Sanfilippo syndrome type B. Proc Natl Acad Sci U S A 93:6101-6105 (Pubitemid 26190810)